Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Task force says some women can benefit from risk-reducing drugs like tamoxifen, but women at average risk should not take them.
A large analysis finds hormone replacement therapy increases the risk about twice as much as previously thought.
Mental health care before cancer treatment is associated with higher death rates for those with kidney, prostate or bladder cancer.
These men lived for a median of 30 months compared to 26 months for white men.
Genetic test can help guide decisions about treatment after surgery.
Doctors recommend several ways to treat this common side effect of hormone therapy.
New study suggests longer hormone therapy may help prevent cancer recurrence.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.